Effect of a High Protein Diet on the 24-hour Profile of Ghrelin, GH (Growth Hormone) and IGF-1 (Insulin-like Growth Factor-1)
Diabetes Mellitus, Type 2

About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring Cholesterol, Creatinine Clearance, Diabetes, Glycohemoglobin, High Protein Diet
Eligibility Criteria
Inclusion Criteria: People ages 55 - 75 years old with type 2 diabetes, not receiving oral hypoglycemic agents or insulin. Fasting plasma glucose < 250 mg/dl (<14 mM) (tGHb < 14%). Exclusion Criteria: Subjects will be screened for hematological abnormalities, liver disease, kidney disease, macroalbuminuria (>300 mg/24 hours), untreated thyroid disease, congestive heart failure, angina, life-threatening malignancies, proliferative retinopathy, diabetic neuropathy, peripheral vascular disease, serious psychological disorders, a body mass index > 35, and a fasting triglyceride of > 400 mg/dl. Presence of any of the above will be considered exclusion criteria.
Sites / Locations
- VA Medical Center, Minneapolis
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Arm 1
Arm 2
30% carbohydrate, 30% protein, 40% fat
55% carbohydrate, 15% protein, 30% fat